AbbVie secures Canadian support for Skyrizi in ulcerative colitis with new reimbursement recommendations and a completed pCPA agreement.

Harvard-trained gastroenterologist Dr. Saurabh Sethi highlights 5 key warning signs of colon cancer in young people. Early ...

While guideline-concordant post-polypectomy colonoscopy surveillance was associated with a reduced risk of incident ...

SKYRIZI® (risankizumab), an IL-23 inhibitor, received two consecutive positive reimbursement recommendations by Canada’s Drug ...

Ulcerative colitis (UC) is one of the most common inflammatory bowel diseases, a lifelong condition that can cause chronic ...

Engineered T cells that have been used to treat ulcerative colitis, rheumatoid arthritis and lupus show promising results.

The iSNP systems genomics pipeline models how non-coding SNPs cumulatively impact cellular signalling and gene regulatory networks, revealing patient-specific mechanisms linking disease-associated ...

Aeromonas, toxic bacteria, may by kill body’s defensive immune cells, causing ulcerative colitis (inflammatory bowel disease) ...

EXERCISE has long been celebrated as one of the most effective ways to prevent cancer and promote overall health.

As cancer treatment evolves, health systems are adapting by providing oncology urgent care clinics to patients.

When addressing the serious concern of colon cancer, many people wonder about the effectiveness of standard imaging tools ...